Article Information
- Received November 13, 2012
- Revision received June 14, 2013
- Accepted July 8, 2013
- First published August 14, 2013.
- Version of record published August 14, 2013.
Author Information
Author contributions
Author contributions: M.K., L.M., and F.V. designed research; M.K., D.X., N.S., K.M.T., T.B., and M.L.S. performed research; M.K., D.X., N.S., K.M.T., and F.V. analyzed data; M.K. and F.V. wrote the paper.
↵*D.X. and N.S. contributed equally to this work.
Disclosures
- Received November 13, 2012.
- Revision received June 14, 2013.
- Accepted July 8, 2013.
This work was supported by P01 NS062686-04 and R01 NS060750 from the National Institute of Neurological Disorders and Stroke. M.K. was supported by a fellowship from the Swedish Brain Foundation (Hjarnfonden) and N.S. by a fellowship from the Fonds de Recherche en Sante du Quebec (2009–2012) and the Canadian Institute of Health Research (2012–present). We thank Drs. Charles Stiles and John Alberta at Dana Farber Cancer Institute, Boston, for their gift of Olig2 antibody and Dr. Kazuaki Yoshikawa at Osaka University, Japan, for his gift of Dlx-2 antibody. We thank Dr. Hanna Stevens and Dr. Karen Muller-Smith for useful discussions. Dr. George Anderson, Yale Child Study Center, is greatly acknowledged for technical advice about HPLC. We acknowledge Dr. Simone Tomasi, Elise Cheng, Suzannah Luft, Devon Fagel, and Dr. Teresa Sandoval-Minero for useful discussions and technical help.
The authors declare no competing financial interests.
- Correspondence should be addressed to Flora Vaccarino, Child Study Center, 230 South Frontage Road, New Haven, CT 06520. flora.vaccarino{at}yale.edu
